NeuroPace director granted shares and stock options
NeuroPace Inc director Frank M. Fischer received equity compensation consisting of common stock and stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
NeuroPace Inc director Frank M. Fischer received equity compensation consisting of common stock and stock options. He was granted 2,890 shares of common stock at no cost, increasing his direct holdings to 598,067 shares. He was also granted options for 5,368 shares at an exercise price of $15.74 per share, expiring on June 4, 2036.
Both the shares and options vest in twelve equal monthly installments, contingent on his continuous service, which makes this a scheduled, compensation-related award rather than a market purchase or sale.
Insider Trade Summary
Grant/Award: 8,258 shares
Grant/Award
2 txns
Insider
Fischer Frank M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 5,368 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 2,890 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 5,368 contracts (Direct);
Common Stock — 598,067 shares (Direct)
Footnotes (2)
- F1. The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.
- F2. The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.
Key Figures
Common stock grant: 2,890 shares
Holdings after grant: 598,067 shares
Stock options granted: 5,368 options
+4 more
7 metrics
Common stock grant
2,890 shares
Award of NeuroPace common stock to director
Holdings after grant
598,067 shares
Common stock directly held by Frank M. Fischer after award
Stock options granted
5,368 options
New stock option (right to buy) grant
Option exercise price
$15.74 per share
Conversion/exercise price for 5,368 stock options
Option expiration
June 4, 2036
Expiration date of newly granted stock options
Vesting schedule shares
12 monthly installments
Common stock award vesting pattern, subject to continuous service
Vesting schedule options
12 monthly installments
Option shares vesting and becoming exercisable over 12 months
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: "15.7400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-04T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The shares shall vest in twelve (12) equal consecutive monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service financial
"subject to the Reporting Person's continuous service through each vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NeuroPace (NPCE) director Frank M. Fischer report in this Form 4?
Frank M. Fischer reported equity compensation awards. He received 2,890 shares of NeuroPace common stock and stock options for 5,368 shares, both granted at no cash cost to him as part of his director compensation package.
What are the key terms of the stock options granted to Frank M. Fischer at NeuroPace (NPCE)?
Fischer received stock options covering 5,368 NeuroPace shares with a $15.74 exercise price. These options expire on June 4, 2036, and the underlying shares vest in twelve equal monthly installments, subject to his continued service with the company.
How do the new NeuroPace (NPCE) equity awards to Frank M. Fischer vest over time?
Both the 2,890-share common stock award and the 5,368-share option grant vest in twelve equal monthly installments. Each installment requires Frank M. Fischer to remain in continuous service through the applicable vesting date with NeuroPace.
Were the NeuroPace (NPCE) Form 4 transactions open-market buys or sells?
The transactions were not open-market buys or sells. They are coded as “A” awards, representing grants of common stock and stock options as compensation, with no purchase or sale of shares on the open market by Frank M. Fischer.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates